美国淋巴水肿治疗市场预测至 2028 年 - 按病情类型(原发性淋巴水肿和继发性淋巴水肿)、治疗类型(激光治疗、加压装置和绷带、药物治疗、生理程序、减瘤手术等)划分的 COVID-19 影响和国家分析,和最终用户(医院、诊所、临床研究组织等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 132    |    Report Code: BMIRE00028504    |    Category: Life Sciences

US Lymphedema Treatment Market

美国淋巴水肿治疗市场规模预计将从2022年的51.8598亿美元增长到2028年的83.2007亿美元;预计 2023 年至 2028 年复合年增长率为 8.2%。

美国淋巴水肿治疗市场的增长归因于淋巴水肿病例发病率的上升增加医疗保健服务和淋巴水肿管理计划。然而,缺乏意识和熟练的专业人员正在阻碍市场的增长。

淋巴水肿涉及淋巴液在皮下脂肪组织中的积聚。这种情况是由于人的淋巴系统流动受损引起的,可在腿部或手臂或两者中观察到。它还可能影响一个人的腹部、颈部、生殖器和面部,具体取决于接受治疗的身体部位。原发性淋巴水肿一般在出生时就已出现,而继发性淋巴水肿则因淋巴系统功能障碍或受损而引起。

根据美国心脏病学会基金会报告,治疗淋巴水肿主要是由症状管理、体积缩小和感染预防引起的。例如,淋巴水肿的一线治疗是保守治疗。完全减充血疗法(CGT)已成为物理治疗保守治疗的前沿。此外,手术治疗方法可以很好地坚持保守治疗。此外,针对淋巴水肿的新型微创血管化淋巴结转移已引起全世界的广泛关注。例如,亚利桑那州菲尼克斯/斯科茨代尔梅奥诊所院区的医生为患有传统疗法难治性淋巴水肿的患者开发了一种新的门诊手术程序。淋巴结转移的好处包括显着减轻淋巴水肿解剖结构中的疼痛和肿胀。此外,手术还可以让患者减少抗生素的使用,从而提高患者的生活质量。此外,被诊断患有乳腺癌、皮肤阴茎癌、膀胱癌和妇科癌症的患者可能会接受淋巴结手术。

淋巴水肿是一种影响患者身心健康的慢性、无法治愈的疾病。存在。事实证明,定期护理是一种多学科的患者管理方法。定期护理团队包括来自身体康复、血管医学、整形外科、放射科、肿瘤科、传染病科和社会工作领域的人员。该团队可以提供全面的评估,以评估肢体肿胀的病因,优化保守治疗,并为合适的候选人提供手术治疗。

MedStar Health 报告指出,患者的淋巴水肿治疗计划将取决于病情的原因和严重程度。医生可能会开药或转介专门从事淋巴水肿治疗的物理或职业治疗师。治疗方法包括通过锻炼、特殊按摩技术或机械泵装置来减轻肿胀和控制疼痛。如果患者病情严重,医生可能会推荐更先进的治疗方法,例如淋巴结转移和淋巴静脉旁路术。

梅奥医学教育和研究基金会报告指出,与以前使用的腹腔镜检查相比,用于淋巴手术的机器人技术具有更大的灵活性和精度。此外,事实证明,机器人技术的使用对于外科医生和患者的治疗效果都是最佳的,并将在预测期内显示出积极的结果。例如,2020 年 5 月接受单机器人淋巴水肿手术的患者提供了积极的轶事反馈,包括显着的临床改善,例如能够穿着外科医生取得的重大成就的衣服。此外,具有人工智能(AI)功能的机器人越来越多地协助淋巴水肿手术中的显微外科手术,以减少可能影响患者康复的外科医生差异。例如,对于淋巴水肿手术,2020 年 5 月,一名泌尿妇科外科医生利用免费淋巴结转移进行了首例单端口机器人精神采集,旨在用于淋巴水肿的微创手术治疗。这种新的手术治疗方法的主要目标是最大限度地减少供区淋巴水肿症状的发病率。

基于治疗的见解

< /h3>

根据治疗,美国淋巴水肿治疗市场分为激光疗法、压迫装置和绷带、药物疗法、生理手术、减瘤手术等。生理手术部分进一步分为淋巴静脉吻合术(LVA)和血管化淋巴结转移(VLNT)。同样,减瘤手术又细分为手术减瘤、抽脂术等。压缩设备和绷带细分市场在 2022 年占据最大市场份额。预计生理手术细分市场在预测期内复合年增长率最高,这主要是由于通过 LVA 和 VLNT 对淋巴水肿患者进行治疗的可用性。目前采用两种主要的生理干预措施来治疗淋巴水肿。主要干预措施是在充血的淋巴管之间创建一个分流器(一个孔或一个小通道,以促进运动),使静脉系统靠近淋巴阻塞的位置。另一种生理干预包括血管化软组织瓣,通常包括受影响淋巴管末端的血管化淋巴结。在这一细分市场中,血管化淋巴结转移(VLNT)手术将在预测年内以最高复合年增长率增长。北美放射学会 (RSNA) 指出,淋巴水肿治疗传统上是保守且有限的,但如今外科手术和显微外科手术已大幅增加。例如,VLNT 是显微手术中最突出和最有前途的技术之一。 VLNT 涉及将功能性淋巴结 (LN) 从健康的供体部位转移到身体淋巴引流受损或患病的区域。



US Lymphedema Treatment Strategic Insights

Strategic insights for US Lymphedema Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/us-lymphedema-treatment-market-strategic-framework.webp
Get more information on this report

US Lymphedema Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 5,185.98 Million
Market Size by 2028 US$ 8,320.07 Million
Global CAGR (2023 - 2028) 8.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 病情类型
  • 原发性淋巴水肿
  • 继发性淋巴水肿
By 治疗类型
  • 激光治疗
  • 压迫装置及绷带
  • 药物治疗
  • 生理程序
  • 减瘤手术
By 最终用户
  • 医院
  • 诊所
  • 临床研究组织
Regions and Countries Covered 美国
  • 美国
Market leaders and key company profiles
  • BIOCOMPRESSION SYSTEMS
  • Tactile Medical
  • Smith & Nephew
  • Essity AB
  • Lohmann & Rauscher GmbH & Co. KG
  • SIGVARIS GROUP
  • ThermoTek
  • Huntleigh Healthcare Limited
  • 3M
  • Airos Medical, Paul Hartmann AG
  • Get more information on this report

    US Lymphedema Treatment Regional Insights

    The regional scope of US Lymphedema Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/us-lymphedema-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - US Lymphedema Treatment Market

    1. BIOCOMPRESSION SYSTEMS
    2. Tactile Medical
    3. Smith & Nephew
    4. Essity AB
    5. Lohmann & Rauscher GmbH & Co. KG
    6. SIGVARIS GROUP
    7. ThermoTek
    8. Huntleigh Healthcare Limited
    9. 3M
    10. Airos Medical, Paul Hartmann AG
    Frequently Asked Questions
    How big is the US Lymphedema Treatment Market?

    The US Lymphedema Treatment Market is valued at US$ 5,185.98 Million in 2022, it is projected to reach US$ 8,320.07 Million by 2028.

    What is the CAGR for US Lymphedema Treatment Market by (2023 - 2028)?

    As per our report US Lymphedema Treatment Market, the market size is valued at US$ 5,185.98 Million in 2022, projecting it to reach US$ 8,320.07 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.

    What segments are covered in this report?

    The US Lymphedema Treatment Market report typically cover these key segments-

  • 病情类型 (原发性淋巴水肿, 继发性淋巴水肿)
  • 治疗类型 (激光治疗, 压迫装置及绷带, 药物治疗, 生理程序, 减瘤手术)
  • 最终用户 (医院, 诊所, 临床研究组织)
  • What is the historic period, base year, and forecast period taken for US Lymphedema Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Lymphedema Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in US Lymphedema Treatment Market?

    The US Lymphedema Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BIOCOMPRESSION SYSTEMS
  • Tactile Medical
  • Smith & Nephew
  • Essity AB
  • Lohmann & Rauscher GmbH & Co. KG
  • SIGVARIS GROUP
  • ThermoTek
  • Huntleigh Healthcare Limited
  • 3M
  • Airos Medical, Paul Hartmann AG
  • Who should buy this report?

    The US Lymphedema Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the US Lymphedema Treatment Market value chain can benefit from the information contained in a comprehensive market report.